Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens

Michael Cho, Jessica M. Atrio, Aaron H. Lim, Colleen Azen, Frank Z. Stanczyk

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: The objective was to investigate changes in luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and progesterone (P) during the hormone-free interval (HFI) of 6 combined oral contraceptives (COCs). Design: Blood samples were obtained from 62 women. Results: When COCs were grouped by ethinyl estradiol (EE) dose, there was a significant positive mean slope for LH and FSH during the HFI for the 30- and 35 mcg-EE doses, whereas 20 showed a gradual nonsignificant slope. All E 2 slopes were significant. P remained suppressed with all doses. Conclusion: A more rapid rebound of gonadotropin levels is found with higher doses of EE during the HFI. Implications: This study showed a more rapid rebound of pituitary hormone levels among women using higher-EE-dosage formulations, which was demonstrated by the statistically significant slope for mean LH and FSH from day 1 to day 7 of the HFI. The degree of suppression did not vary across progestin generations. It remains to be established whether women who experience side effects during their HFI may benefit from using a COC with a lower EE dose to minimize changes in endogenous pituitary hormone levels.

Original languageEnglish (US)
Pages (from-to)94-96
Number of pages3
JournalContraception
Volume90
Issue number1
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Contraceptives, Oral, Combined
Ethinyl Estradiol
Pituitary Hormones
Hormones
Follicle Stimulating Hormone
Luteinizing Hormone
Progestins
Gonadotropins
Progesterone
Estradiol

Keywords

  • Contraceptive efficacy
  • Estradiol
  • Ethinyl estradiol
  • Gonadotropins
  • Hypothalamic-pituitary-ovarian axis
  • Progesterone

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens. / Cho, Michael; Atrio, Jessica M.; Lim, Aaron H.; Azen, Colleen; Stanczyk, Frank Z.

In: Contraception, Vol. 90, No. 1, 2014, p. 94-96.

Research output: Contribution to journalArticle

Cho, Michael ; Atrio, Jessica M. ; Lim, Aaron H. ; Azen, Colleen ; Stanczyk, Frank Z. / Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens. In: Contraception. 2014 ; Vol. 90, No. 1. pp. 94-96.
@article{8e643946b25248bda83e52cdcde4c04b,
title = "Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens",
abstract = "Objective: The objective was to investigate changes in luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and progesterone (P) during the hormone-free interval (HFI) of 6 combined oral contraceptives (COCs). Design: Blood samples were obtained from 62 women. Results: When COCs were grouped by ethinyl estradiol (EE) dose, there was a significant positive mean slope for LH and FSH during the HFI for the 30- and 35 mcg-EE doses, whereas 20 showed a gradual nonsignificant slope. All E 2 slopes were significant. P remained suppressed with all doses. Conclusion: A more rapid rebound of gonadotropin levels is found with higher doses of EE during the HFI. Implications: This study showed a more rapid rebound of pituitary hormone levels among women using higher-EE-dosage formulations, which was demonstrated by the statistically significant slope for mean LH and FSH from day 1 to day 7 of the HFI. The degree of suppression did not vary across progestin generations. It remains to be established whether women who experience side effects during their HFI may benefit from using a COC with a lower EE dose to minimize changes in endogenous pituitary hormone levels.",
keywords = "Contraceptive efficacy, Estradiol, Ethinyl estradiol, Gonadotropins, Hypothalamic-pituitary-ovarian axis, Progesterone",
author = "Michael Cho and Atrio, {Jessica M.} and Lim, {Aaron H.} and Colleen Azen and Stanczyk, {Frank Z.}",
year = "2014",
doi = "10.1016/j.contraception.2014.01.021",
language = "English (US)",
volume = "90",
pages = "94--96",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens

AU - Cho, Michael

AU - Atrio, Jessica M.

AU - Lim, Aaron H.

AU - Azen, Colleen

AU - Stanczyk, Frank Z.

PY - 2014

Y1 - 2014

N2 - Objective: The objective was to investigate changes in luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and progesterone (P) during the hormone-free interval (HFI) of 6 combined oral contraceptives (COCs). Design: Blood samples were obtained from 62 women. Results: When COCs were grouped by ethinyl estradiol (EE) dose, there was a significant positive mean slope for LH and FSH during the HFI for the 30- and 35 mcg-EE doses, whereas 20 showed a gradual nonsignificant slope. All E 2 slopes were significant. P remained suppressed with all doses. Conclusion: A more rapid rebound of gonadotropin levels is found with higher doses of EE during the HFI. Implications: This study showed a more rapid rebound of pituitary hormone levels among women using higher-EE-dosage formulations, which was demonstrated by the statistically significant slope for mean LH and FSH from day 1 to day 7 of the HFI. The degree of suppression did not vary across progestin generations. It remains to be established whether women who experience side effects during their HFI may benefit from using a COC with a lower EE dose to minimize changes in endogenous pituitary hormone levels.

AB - Objective: The objective was to investigate changes in luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and progesterone (P) during the hormone-free interval (HFI) of 6 combined oral contraceptives (COCs). Design: Blood samples were obtained from 62 women. Results: When COCs were grouped by ethinyl estradiol (EE) dose, there was a significant positive mean slope for LH and FSH during the HFI for the 30- and 35 mcg-EE doses, whereas 20 showed a gradual nonsignificant slope. All E 2 slopes were significant. P remained suppressed with all doses. Conclusion: A more rapid rebound of gonadotropin levels is found with higher doses of EE during the HFI. Implications: This study showed a more rapid rebound of pituitary hormone levels among women using higher-EE-dosage formulations, which was demonstrated by the statistically significant slope for mean LH and FSH from day 1 to day 7 of the HFI. The degree of suppression did not vary across progestin generations. It remains to be established whether women who experience side effects during their HFI may benefit from using a COC with a lower EE dose to minimize changes in endogenous pituitary hormone levels.

KW - Contraceptive efficacy

KW - Estradiol

KW - Ethinyl estradiol

KW - Gonadotropins

KW - Hypothalamic-pituitary-ovarian axis

KW - Progesterone

UR - http://www.scopus.com/inward/record.url?scp=84901779545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901779545&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2014.01.021

DO - 10.1016/j.contraception.2014.01.021

M3 - Article

VL - 90

SP - 94

EP - 96

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 1

ER -